Genetic evidence that apolipoprotein E4 is not a relevant susceptibility factor for cholelithiasis in two high-risk populations

Journal of Lipid Research

Volumn 48, Issue 6, 2007, Pages 1378-1385

  Mella, Juan G ^a   Schirin Sokhan, Ramin ^b   Rigotti, Attilio ^a   Pimentel, Fernando ^a   Villarroel, Luis ^a   Wasmuth, Hermann E ^b   Sauerbruch, Tilman ^c   Nervi, Flavio ^a   Lammert, Frank ^b,c   Miquel, Juan Francisco ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c UNIVERSITY HOSPITAL BONN   (Germany)

Author keywords

Cholesterol; Gallstone disease; Genetic association study

Indexed keywords

APOLIPOPROTEIN E4; CHOLESTEROL; GLUCOSE; LIPID;

ADULT; AGED; ALLELE; ARTICLE; BODY MASS; CHILE; CHOLECYSTECTOMY; CHOLELITHIASIS; CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GALLSTONE; GENOTYPE; GERMANY; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK; RISK FACTOR; SEX DIFFERENCE;

ADULT; ALLELES; APOLIPOPROTEIN E4; BODY MASS INDEX; CASE-CONTROL STUDIES; CHILE; CHOLELITHIASIS; CHOLESTEROL; FEMALE; GALLSTONES; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERMANY; HUMANS; LIPOPROTEINS; MALE; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC;

EID: 34548152844     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M700059-JLR200     Document Type: Article

References (67)

1. Portincasa, P., A. Moschetta, and G. Palasciano. 2006. Cholesterol gallstone disease. Lancet. 368: 230-239.
2. Paigen, B., and M. C. Carey. 2002. Gallstones. In Genetic Basis of Common Diseases. R. A. King, J. I. Rotter, and A. G. Motulsky, editors. Oxford University Press, New York. 298-335.
3. Carey, M. C. 1993. Pathogenesis of gallstones. Am. J. Surg. 165: 410-419.
4. Lammert, F., and T. Sauerbruch. 2005. Mechanisms of disease: the genetic epidemiology of gallbladder stones. Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 423-433.
5. Everhart, J. E. 2001. Gallstones and ethnicity in the Americas. J. Assoc. Acad. Minor. Phys. 12: 137-143.
6. Everhart, J. E., M. Khare, M. Hill, and K. R. Maurer. 1999. Prevalence and ethnic differences in gallbladder disease in the United States. Gastroenterology. 117: 632-639.
7. Barbara, L., C. Sama, A. M. Morselli Labate, F. Taroni, A. G. Rusticali, D. Festi, C. Sapio, E. Roda, C. Banterle, A. Puci, et al. 1987. A population study on the prevalence of gallstone disease: the Sirmione Study. Hepatology. 7: 913-917.
8. Miquel, J. F., C. Covarrubias, L. Villaroel, G. Mingrone, A. V. Greco, L. Puglielli, P. Carvallo, G. Marshall, G. Del Pino, and F. Nervi. 1998. Genetic epidemiology of cholesterol cholelithiasis among Chilean Hispanics, Amerindians, and Maoris. Gastroenterology. 115: 937-946.
9. Puppala, S., G. D. Dodd, S. Fowler, R. Arya, J. Schneider, V. S. Farook, R. Granato, T. D. Dyer, L. Almasy, C. P. Jenkinson, et al. 2006. A genomewide search finds major susceptibility loci for gallbladder disease on chromosome 1 in Mexican Americans. Am. J. Hum. Genet. 78: 377-392.
10. Nakeeb, A., A. G. Comuzzie, L. Martin, G. E. Sonnenberg, D. Swartz-Basile, A. H. Kissebah, and H. A. Pitt. 2002. Gallstones: genetics versus environment. Ann. Surg. 235: 842-849.
11. Katsika, D., A. Grjibovski, C. Einarsson, F. Lammert, P. Lichtenstein, and H. U. Marschall. 2005. Genetic and environmental influences on symptomatic gallstone disease: a Swedish study of 43,141 twin pairs. Hepatology. 41: 1138-1143.
12. Sutor, D. J., and S. E. Wooley. 1971. A statistical survey of the composition of gallstones in eight countries. Gut. 12: 55-64.
13. Cooper, A. D. 1991. Metabolic basis of cholesterol gallstone disease. Gastroenterol. Clin. North Am. 20: 21-46.
14. Petitti, D. B., G. D. Friedman, and A. L. Klatsky. 1981. Association of a history of gallbladder disease with a reduced concentration of high-density-lipoprotein cholesterol. N. Engl. J. Med. 304: 1396-1398.
15. Thijs, C., P. Knipschild, and P. Brombacher. 1990. Serum lipids and gallstones: a case-control study. Gastroenterology. 99: 843-849.
16. Mohr, G. C., D. Kritz-Silverstein, and E. Barrett-Connor. 1991. Plasma lipids and gallbladder disease. Am. J. Epidemiol. 134: 78-85.
17. Busch, N., F. Lammert, and S. Matern. 1998. Biliary secretory immunoglobulin A is a major constituent of the new group of cholesterol crystal-binding proteins. Gastroenterology. 115: 129-138.
18. Busch, N., F. Lammert, H. U. Marschall, and S. Matern. 1995. A new subgroup of lectin-bound biliary proteins binds to cholesterol crystals, modifies crystal morphology, and inhibits cholesterol crystallization. J. Clin. Invest. 96: 3009-3015.
19. Miquel, J. F., L. Nunez, A. Rigotti, L. Amigo, E. Brandan, and F. Nervi. 1993. Isolation and partial characterization of cholesterol pronucleating hydrophobic glycoproteins associated to native biliary vesicles. FEBS Lett. 318: 45-49.
20. Mahley, R. W. 1988. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science. 240: 622-630.
21. Miettinen, T. A. 1991. Impact of apo E phenotype on the regulation of cholesterol metabolism. Ann. Med. 23: 181-186.
22. Utermann, G., A. Steinmetz, and W. Weber. 1982. Genetic control of human apolipoprotein E polymorphism: comparison of oneand two-dimensional techniques of isoprotein analysis. Hum. Genet. 60: 344-351.
23. Zannis, V. I., J. L. Breslow, G. Utermann, R. W. Mahley, K. H. Weisgraber, R. J. Havel, J. L. Goldstein, M. S. Brown, G. Schonfeld, W. R. Hazzard, et al. 1982. Proposed nomenclature of apoE isoproteins, apoE genotypes, and phenotypes. J. Lipid Res. 23: 911-914.
24. Weisgraber, K. H., T. L. Innerarity, and R. W. Mahley. 1982. Abnormal lipoprotein receptor-binding activity of the human E apoprotein due to cysteine-arginine interchange at a single site. J. Biol. Chem. 257: 2518-2521.
25. Kesaniemi, Y. A., and T. A. Miettinen. 1988. Metabolic epidemiology of plasma cholesterol. Ann. Clin. Res. 20: 26-31.
26. Tiret, L., P. de Knijff, H. J. Menzel, C. Ehnholm, V. Nicaud, and L. M. Havekes. 1994. ApoE polymorphism and predisposition to coronary heart disease in youths of different European populations. The EARS Study. European Atherosclerosis Research Study. Arterioscler. Thromb. 14: 1617-1624.
27. Evans, R. M., S. Hui, A. Perkins, D. K. Lahiri, J. Poirier, and M. R. Farlow. 2004. Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology. 62: 1869-1871.
28. Juvonen, T., K. Kervinen, M. I. Kairaluoma, L. H. Lajunen, and Y. A. Kesaniemi. 1993. Gallstone cholesterol content is related to apolipoprotein E polymorphism. Gastroenterology. 104: 1806-1813.
29. Bertomeu, A., E. Ros, D. Zambon, M. Vela, R. M. Perez-Ayuso, E. Targarona, M. Trias, C. Sanllehy, E. Casals, and J. M. Ribo. 1996. Apolipoprotein E polymorphism and gallstones. Gastroenterology. 111: 1603-1610.
30. Niemi, M., K. Kervinen, A. Rantala, H. Kauma, M. Paivansalo, M. J. Savolainen, M. Lilja, and Y. A. Kesaniemi. 1999. The role of apolipoprotein E and glucose intolerance in gallstone disease in middle aged subjects. Gut. 44: 557-562.
31. Lin, Q. Y., J. P. Du, M. Y. Zhang, Y. G. Yao, L. Li, N. S. Cheng, L. N. Yan, and L. J. Xiao. 1999. Effect of apolipoprotein E gene Hha I restricting fragment length polymorphism on serum lipids in cholecystolithiasis. World J. Gastroenterol. 5: 228-230.
32. Hasegawa, K., S. Terada, K. Kubota, H. Itakura, H. Imamura, S. Ohnishi, T. Aoki, M. Ijichi, A. Saiura, and M. Makuuchi. 2003. Effect of apolipoprotein E polymorphism on bile lipid composition and the formation of cholesterol gallstone. Am. J. Gastroenterol. 98: 1605-1609.
33. Dixit, M., G. Choudhuri, and B. Mittal. 2006. Association of APOEC-1 gene cluster polymorphisms with gallstone disease. Dig. Liver Dis. 38: 397-403.
34. Ko, C. W., S. A. Beresford, B. Alderman, G. P. Jarvik, S. J. Schulte, B. Calhoun, A. M. Tsuchida, T. D. Koepsell, and S. P. Lee. 2000. Apolipoprotein E genotype and the risk of gallbladder disease in pregnancy. Hepatology. 31: 18-23.
35. Fischer, S., M. H. Dolu, B. Zundt, G. Meyer, S. Geisler, and D. Jungst. 2001. Apolipoprotein E polymorphism and lithogenic factors in gallbladder bile. Eur. J. Clin. Invest. 31: 789-795.
36. Weintraub, M. S., S. Eisenberg, and J. L. Breslow. 1987. Dietary fat clearance in normal subjects is regulated by genetic variation in apolipoprotein E. J. Clin. Invest. 80: 1571-1577.
37. Gylling, H., and T. A. Miettinen. 1992. Cholesterol absorption and synthesis related to low density lipoprotein metabolism during varying cholesterol intake in men with different apoE phenotypes. J. Lipid Res. 33: 1361-1371.
38. Angelin, B., L. Holmquist, B. Leijd, and K. Einarsson. 1990. Bile acid metabolism in familial dysbetalipoproteinaemia: studies in subjects with the apolipoprotein E-2/2 phenotype. Eur. J. Clin. Invest. 20: 143-149.
39. Van Erpecum, K. J., G. P. Van Berge-Henegouwen, E. R. Eckhardt, P. Portincasa, B. J. Van De Heijning, G. M. Dallinga-Thie, and A. K. Groen. 1998. Cholesterol crystallization in human gallbladder bile: relation to gallstone number, bile composition, and apolipoprotein E4 isoform. Hepatology. 27: 1508-1516.
40. Marinovic, I., C. Guerra, and G. Larach. 1972. Incidence of cholelithiasis in autopsy material and analysis of the composition of calculi. [In Spanish.] Rev. Med. Chil. 100: 1320-1327.
41. Volzke, H., S. E. Baumeister, D. Alte, W. Hoffmann, C. Schwahn, P. Simon, U. John, and M. M. Lerch. 2005. Independent risk factors for gallstone formation in a region with high cholelithiasis prevalence. Digestion. 71: 97-105.
42. Amigo, L., S. Zanlungo, H. Mendoza, J. F. Miquel, and F. Nervi. 1999. Risk factors and pathogenesis of cholesterol gallstones: state of the art. Eur. Rev. Med. Pharmacol. Sci. 3: 241-246.
43. Maurer, K. R., J. E. Everhart, W. C. Knowler, T. H. Shawker, and H. P. Roth. 1990. Risk factors for gallstone disease in the Hispanic populations of the United States. Am. J. Epidemiol. 131: 836-844.
44. Hixson, J. E., and D. T. Vernier. 1990. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31: 545-548.
45. Dallinga-Thie, G. M., M. van Linde-Sibenius Trip, L. A. Kock, and T. W. De Bruin. 1995. Apolipoprotein E2/E3/E4 genotyping with agarose gels. Clin. Chem. 41: 73-75.
46. Lahiri, D. K., and J. I. Nurnberger, Jr. 1991. A rapid non-enzymatic method for the preparation of HMW DNA from blood for RFLP studies. Nucleic Acids Res. 19: 5444.
47. Emi, M., L. L. Wu, M. A. Robertson, R. L. Myers, R. A. Hegele, R. R. Williams, R. White, and J. M. Lalouel. 1988. Genotyping and sequence analysis of apolipoprotein E isoforms. Genomics. 3: 373-379.
48. Nunez, L., L. Amigo, G. Mingrone, A. Rigotti, L. Puglielli, A. Raddatz, F. Pimentel, A. V. Greco, S. Gonzalez, J. Garrido, et al. 1995. Biliary aminopeptidase-N and the cholesterol crystallisation defect in cholelithiasis. Gut. 37: 422-426.
49. Fromm, H., P. Amin, H. Klein, and I. Kupke. 1980. Use of a simple enzymatic assay for cholesterol analysis in human bile. J. Lipid Res. 21: 259-261.
50. Miquel, J. F., L. Nunez, L. Amigo, S. Gonzalez, A. Raddatz, A. Rigotti, and F. Nervi. 1998. Cholesterol saturation, not proteins or cholecystitis, is critical for crystal formation in human gallbladder bile. Gastroenterology. 114: 1016-1023.
51. Carey, M. C. 1978. Critical tables for calculating the cholesterol saturation of native bile. J. Lipid Res. 19: 945-955.
52. Gamboa, R., G. Hernandez-Pacheco, R. Hesiquio, J. Zuniga, F. Masso, L. F. Montano, M. Ramos-Kuri, J. Estrada, J. Granados, and G. Vargas-Alarcon. 2000. Apolipoprotein E polymorphism in the Indian and Mestizo populations of Mexico. Hum. Biol. 72: 975-981.
53. Van Erpecum, K. J., and M. C. Carey. 1996. Apolipoprotein E4: another risk factor for cholesterol gallstone formation? Gastroenterology. 111: 1764-1767.
54. Venneman, N. G., G. P. vanBerge-Henegouwen, P. Portincasa, M. F. Stolk, A. Vos, P. W. Plaisier, and K. J. van Erpecum. 2001. Absence of apolipoprotein E4 genotype, good gallbladder motility and presence of solitary stones delay rather than prevent gallstone recurrence after extracorporeal shock wave lithotripsy. J. Hepatol. 35: 10-16.
55. Amigo, L., V. Quinones, P. Mardones, S. Zanlungo, J. F. Miquel, F. Nervi, and A. Rigotti. 2000. Impaired biliary cholesterol secretion and decreased gallstone formation in apolipoprotein E-deficient mice fed a high-cholesterol diet. Gastroenterology. 118: 772-779.
56. Hanis, C. L., D. Hewett-Emmett, L. F. Kubrusly, M. N. Maklad, T. C. Douglas, W. H. Mueller, S. A. Barton, H. Yoshimaru, D. B. Kubrusly, R. Gonzalez, et al. 1993. An ultrasound survey of gallbladder disease among Mexican Americans in Starr County, Texas: frequencies and risk factors. Ethn. Dis. 3: 32-43.
57. Hanis, C. L., R. E. Ferrell, B. R. Tulloch, and W. J. Schull. 1985. Gallbladder disease epidemiology in Mexican Americans in Starr County, Texas. Am. J. Epidemiol. 122: 820-829.
58. Weiss, K. M., R. E. Ferrell, C. L. Hanis, and P. N. Styne. 1984. Genetics and epidemiology of gallbladder disease in New World native peoples. Am. J. Hum. Genet. 36: 1259-1278.
59. Carey, M. C., and B. Paigen. 2002. Epidemiology of the American Indians' burden and its likely genetic origins. Hepatology. 36: 781-791.
60. Nervi, F., J. F. Miquel, and G. Marshall. 2003. The Amerindian epidemics of cholesterol gallstones: the North and South connection [letter]. Hepatology. 37: 947-948; author reply 948-949.
61. Sen, S., J. M. Satagopan, and G. A. Churchill. 2005. Quantitative trait locus study design from an information perspective. Genetics. 170: 447-464.
62. Darvasi, A., and M. Soller. 1994. Selective DNA pooling for determination of linkage between a molecular marker and a quantitative trait locus. Genetics. 138: 1365-1373.
63. Gerdes, L. U., I. C. Klausen, I. Sihm, and O. Faergeman. 1992. Apolipoprotein E polymorphism in a Danish population compared to findings in 45 other study populations around the world. Genet. Epidemiol. 9: 155-167.
64. Muros, M., and C. Rodriguez-Ferrer. 1996. Apolipoprotein E polymorphism influence on lipids, apolipoproteins and Lp(a) in a Spanish population underexpressing apo E4. Atherosclerosis. 121: 13-21.
65. de Knijff, P., A. M. van den Maagdenberg, R. R. Frants, and L. M. Havekes. 1994. Genetic heterogeneity of apolipoprotein E and its influence on plasma lipid and lipoprotein levels. Hum. Mutat. 4: 178-194.
66. Utermann, G. 1987. Apolipoprotein E polymorphism in health and disease. Am. Heart J. 113: 433-440.
67. van Erpecum, K. J., P. Portincasa, M. H. Dohlu, G. P. van Berge-Henegouwen, and D. Jungst. 2003. Biliary pronucleating proteins and apolipoprotein E in cholesterol and pigment stone patients. J. Hepatol. 39: 7-11.